Jamie Findlow | Senior Director, Global Medical Strategy Lead, Meningococcal Vaccines
pfizer

Dr Findlow obtained a Bachelor of Science (Honours) in Molecular and Cellular Biology, graduating in 2000. He subsequently joined the Vaccine Evaluation Unit (VEU) at the Public Health Laboratory Service in Manchester, UK, where he served as a Clinical Scientist focusing on the serological assessment of vaccines. Dr Findlow was awarded a PhD by Manchester Metropolitan University for his thesis entitled “Serological correlates for and Immunogenicity of candidate serogroup B Neisseria meningitidis vaccines.” During his tenure at the laboratory, Dr Findlow assumed roles of increasing responsibility, supporting the organisation through its transitions from the PHLS to the Health Protection Agency, and ultimately to Public Health England. In 2007, he was appointed Deputy Head of the VEU, a role he held for a decade. In 2017, Dr Findlow joined Pfizer as Medical Director within the regional meningococcal vaccine team and in 2018 transferred to the global organisation. He currently serves as the Global Medical Strategy Lead for meningococcal vaccines. Over the course of his career, Dr Findlow has published more than 100 scientific peer-reviewed articles relating to epidemiology and vaccines.